NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aclipse Therapeutics

Aclipse Therapeutics

Private
King of Prussia, PennsylvaniaHealthcare & Life Scienceshttps://aclipsetherapeutics.com/

Last Round

Grant

Apr 20, 2022

Total Funding Raised

$4.4M

Company Overview

Aclipse Therapeutics is a biopharmaceutical company that develops novel and differentiated drugs to treat diseases with significant unmet medical needs, focusing on neuromuscular and gastrointestinal disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalprecision medicineorphan drugdrug developmentamyotrophic lateral sclerosisALSgastroparesisclinical trialsbiomarkersmall moleculein-licensingbiotech startupneurodegenerative diseasedrug discoveryclinical-stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aclipse Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Aclipse Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aclipse Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 20, 2022
GrantJan 26, 2021
Series ASep 30, 2020
GrantSep 29, 2020

Aclipse Therapeutics Investors

Notable investors and investment history

Aclipse Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aclipse Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aclipse Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersKing of Prussia, Pennsylvania
Employee Range10
Year Founded2017
Last FundingApr 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.